Novogen Limited (KZIA)
(Delayed Data from NSDQ)
$0.29 USD
+0.02 (6.02%)
Updated May 16, 2024 03:58 PM ET
After-Market: $0.30 +0.01 (1.94%) 6:28 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Novogen Limited [KZIA]
Reports for Purchase
Showing records 41 - 46 ( 46 total )
Company: Novogen Limited
Industry: Medical - Biomedical and Genetics
Company: Novogen Limited
Industry: Medical - Biomedical and Genetics
Company: Novogen Limited
Industry: Medical - Biomedical and Genetics
GDC-0084 and Cantrixil trials progressing
Provider: Edison Investment Research Limited
Analyst: HULME D
Company: Novogen Limited
Industry: Medical - Biomedical and Genetics
GDC-0084 and Cantrixil trials progressing
Provider: Edison Investment Research Limited
Analyst: HULME D
Company: Novogen Limited
Industry: Medical - Drugs
GDC-0084 Phase II underway
Provider: EDISON INVESTMENT RESEARCH LIMITED
Company: Novogen Limited
Industry: Medical - Drugs
We are discontinuing coverage of due to better allocate resources within our coverage universe
Provider: H.C. Wainwright & Co., Inc.